Standalone figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 | 175 | 206 | 167 | 166 | 196 | 217 | 60 | 66 | 67 | 70 | 67 | |
| COGS | 86 | 72 | 92 | 61 | 58 | 76 | 81 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 100 | 103 | 114 | 106 | 107 | 120 | 137 | — | — | — | — | — |
| 99 | 104 | 102 | 105 | 113 | 109 | 111 | 49 | 55 | 55 | 56 | 55 | |
| 1 | -1 | 12 | 1 | -6 | 11 | 26 | 10 | 12 | 12 | 15 | 12 | |
| OPM % | 0.4% | -0.4% | 5.9% | 0.7% | -3.7% | 5.6% | 12% | 17.3% | 17.8% | 18.1% | 20.6% | 17.9% |
| Depreciation | 12 | 12 | 13 | 13 | 13 | 13 | 13 | 2 | 2 | 2 | 1 | 1 |
| Interest | 7 | 8 | 8 | 8 | 8 | 7 | 7 | 3 | 3 | 1 | 1 | 1 |
| 18 | 19 | 50 | 8 | 44 | 18 | 18 | 2 | 42 | 0 | -8 | 0 | |
| Profit before tax | 0 | -2 | 42 | -11 | 17 | 9 | 24 | 8 | 50 | 10 | 4 | 10 |
| Tax | 1 | 0 | 9 | -1 | 6 | 3 | 10 | 2 | 57 | 4 | -53 | 3 |
| Tax % | 300% | 4.4% | 21.7% | -8.9% | 36.8% | 39.1% | 42.1% | 29.3% | 112.8% | 34.7% | -1,295.1% | 25.5% |
| -0 | -2 | 33 | -10 | 11 | 5 | 14 | 6 | -6 | 7 | 57 | 7 | |
| PAT margin % | -0.2% | -1.4% | 15.8% | -6.1% | 6.3% | 2.7% | 6.3% | 9.8% | -9.6% | 9.8% | 81.4% | 10.9% |
| EPS (₹) | -0 | -0.2 | 2.1 | -0.6 | 0.7 | 0.3 | 0.9 | 0.4 | -0.4 | 0.4 | 3.6 | 0.5 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | -16.4% | -4.1% | +3% | -23.3% | -11.1% | +11.9% | +5.6% | -64.3% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2021 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Life Science Ingredients | 365.86 | 70.44 | — | 0 |
| Pharmaceuticals | 0 | 0 | — | 0 |
₹ crore by quarter
| -59.9% |
| -65.7% |
| -67.6% |
| +12.8% |
| PAT YoY % | -100.4% | — | — | -636.8% | — | — | -58.2% | — | -161% | +24.5% | +320.6% | +25.9% |